Enzo Biochem Reports Fiscal 2006 First Quarter Operating Results (Hep C)

Enzo Biochem Reports Fiscal 2006 First Quarter Operating Results
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ), a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications and providing laboratory services to the medical community, today

Coffee and tea might reduce liver disease risks
Food Production Daily - 06/12/2005 - Drinking more than two cups of coffee or tea daily appears to cut the risk of chronic liver disease by half, reports new research from America. The principle finding of this large, national, population-based prospective study was that